Health information strategy: challenges ahead for the wider healthcare sector
This article was originally published in Clinica
Executive Summary
Developments concerning the recognised need in the EU for a comprehensive health information strategy to enhance citizen and patient access to high-quality health and medicines information could have a significant impact on the medical devices sector. The call for such a strategy was made at a half-day conference at the European Parliament, on December 12. Although the focus was heavily on pharmaceuticals, there are clear implications for the need for all those involved in supplying healthcare products to provide improved information, and particularly that which can better inform patients.
You may also be interested in...
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.